Skip to content

Value of Target-controlled Intravenous Anaesthesia (TCIVA) in Spinal Cord Stimulation

Value of Target-controlled Intravenous Anaesthesia (TCIVA) to Optimize Coverage of the Low Back Pain Territory in Patients With Chronic Refractory Postoperative Multifocal Low Back and Legpain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02821897
Acronym
AIVOC
Enrollment
15
Registered
2016-07-04
Start date
2013-03-31
Completion date
2017-11-17
Last updated
2019-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Failed Back Surgery Syndrome

Brief summary

Study design 60 patients Monocenter prospective study Randomized in 2 groups 36 months Objectives Demonstrate the superiority of target controlled intravenous anesthesia versus total anesthesia with the low back paresthesia mapping in at least 95% of patients implanted with a multicolumn lead.

Interventions

PROCEDURETarget-controlled intravenous anaesthesia
PROCEDURETotal anaesthesia

Sponsors

Poitiers University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years and ≤ 80 years * FBSS * Radicular leg et lumbar pain * For more than 3 months after one or many spine surgeries * Mixt pain (radicular leg et lumbar) with Neuropathic status * Failure of conservative treatment * Severe uni or bilateral radicular pain \> 5 / 10

Exclusion criteria

* Age \<18 years and\> 80 years. * BMI \> 30 kg/m2. * Back pain that can be treated by surgery (discogenic, vertebral instability, …) * Contraindication to TCIVA anesthesia under propofol remifentanil * Psychiatric status * Cancer * No signature of informed consent. * Women of childbearing without contraception

Design outcomes

Primary

MeasureTime frame
Postoperative paresthesia coverage >= 50% of the lower lumbar determined using a paresthesia cover mapping6 months.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026